National Cancer Institute - Radiotherapy and Oncology

Putrajaya, Selangor 62250

0 studies enrolling now · 2 studies all time

What they study most

Melanoma

Studies at this site

• A Study to Evaluate Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Melanoma — Completed
• A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma — Running, not enrolling